Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Marketed under the brand names Mounjaro (for diabetes) and Zepbound (for weight management and obstructive sleep apnea), tirzepatide represents a significant advancement in metabolic disease therapy due to its dual mechanism of action
Semaglutide works by regulating appetite and blood sugar levels, helping you feel fuller with smaller portions and reducing cravings
Who is eligible for Noom Med
Understanding these side effects is important for anyone considering or currently using semaglutide
Approval 2022) Tirzepatide Reduces Appetite, Energy Intake, and Fat Mass in People With Type 2 Diabetes (March 01, 2023) Tirzepatide On Ingestive Behavior In Adults With Overweight Or Obesity: A Randomized 6-Week Phase 1 Trial (June 24, 2025) Mounjaro (Tirzepatide) Injection, For Subcutaneous Use (Initial U.S
US$ 22.98
US$ 27.61
US$ 28.91
US$ 25.68
US$ 29.86
US$ 21.94
